A Pilot Text Messaging Intervention to Reduce Smoking in Office-based Buprenorphine and Inpatient Detoxification Patients
| Status: | Completed |
|---|---|
| Conditions: | Smoking Cessation |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/8/2017 |
| Start Date: | March 2015 |
| End Date: | September 2017 |
Mobile Phone Messaging to Support Smoking Cessation Among Office-based Buprenorphine and Inpatient Detoxification Patients: a Pilot Study
The primary purpose of this study is to understand the feasibility of a text messaging
intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve
smoking cessation among opiate and/or alcohol dependent participants discharged from an
inpatient detoxification unit and enrolled in an office-based buprenorphine program patients
(OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of
informational pamphlets and information for a 1800 quit line; and a prescription for a
nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity
of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which
is offered routinely to all inpatients at Bellevue at the time of discharge) versus the
SmokeFreeTXT intervention plus prescriptions for NRT.
intervention developed by the National Cancer Institute, known as Smokefreetxt, to improve
smoking cessation among opiate and/or alcohol dependent participants discharged from an
inpatient detoxification unit and enrolled in an office-based buprenorphine program patients
(OBBP). Participants will be randomized to 1) treatment as usual (TAU) comprised of
informational pamphlets and information for a 1800 quit line; and a prescription for a
nicotine replacement therapy (NRT) (i.e. nicotine replacement patches based on the quantity
of baseline self-reported smoking, or nicotine replacement gum (2mg) #10, for 28 days which
is offered routinely to all inpatients at Bellevue at the time of discharge) versus the
SmokeFreeTXT intervention plus prescriptions for NRT.
Inclusion Criteria:
- self-described every or some day smoker
- diagnosed with opiate dependence and/or alcohol dependence (DSM-IV) per Physician
medical records (MISYS)
- Fluency in English and able to provide a written informed consent
- Currently owning a mobile phone with a working phone number
- Expected to reside in the New York City area for the next 12 months
- Understands and able to respond to the intervention text message
Exclusion Criteria:
- inability to read or understand English
- currently using nicotine replacement therapies (patch, gum, e-cigarettes),
pharmacotherapy for smoking cessation such as bupropion (zyban, wellbutrin),
varenicline (Chantix).
- suicidal or homicidal ideations
- any ongoing psychotic disorder, life-threatening medical or psychiatric condition
- leaves the inpatient detoxification unit prior to completing study enrollment
- is pregnant, nursing or planning to conceive within the duration of the study period
We found this trial at
1
site
New York University School of Medicine NYU School of Medicine has a proud history that...
Click here to add this to my saved trials
